Based on the analysis of urine samples, the new research aims to pinpoint the degree of risk for the progression of prostate cancer.
This latest study is led by the University of East Anglia with the support of Prostate Cancer UK and Movember in collaboration with Nottingham University Hospitals NHS Trust.
The Principal Investigator for the study, Mr Will Green, is reported as observing that, although most patients with low-risk prostate cancer demonstrate slow progression, “prostate cancer is very complex and risk levels vary between each man. There is an urgent need for improvements in diagnosis and predicting outcomes.”
Ascertaining such information will enable the initiation of treatment for those in need whilst reducing over-treatment for those at low risk.
Prostate cancer is the most common cancer in men in the UK and causes approximately 11,000 deaths each year.
Legal advice
If you or a loved one are struggling with the on-going impact of a significant failing in medical care, contact Glynns Solicitors, specialists in medical negligence, to discuss the suitability of making a claim for compensation.
Please call us on 0800 234 3300 (or from a mobile 01275 334030) or complete our Online Enquiry Form.
Share Article With:
|
|
|
|
|
|
